Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens
Article Quality & Performance Metrics
Readership in this journal
PopularRanked #109 of 552 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 552 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
| Reference Key |
r2002clinicalempiric
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Raz R;Chazan B;Kennes Y;Colodner R;Rottensterich E;Dan M;Lavi I;Stamm W; ;; |
| Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Year | 2002 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
female
middle aged
drug resistance
anti-infective agents
trimethoprim
bacterial / genetics
r raz
sulfamethoxazole drug combination / therapeutic use*
urinary tract infections / drug therapy*
women
urinary / therapeutic use*
investigators=[]
affs=[])
pmid:11941541
doi:10.1086/339812
b chazan
collabauthor(name='israeli urinary tract infection group'
cystitis / drug therapy
gene frequency
premenopause
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.